Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Prognostic impact of FDG-PET in surgically treated pathological stage I lung adenocarcinoma.

Higuchi M, Hasegawa T, Osugi J, Suzuki H, Gotoh M.

Ann Thorac Cardiovasc Surg. 2014;20(3):185-91. Epub 2013 Apr 20.

PMID:
23603641
[PubMed - in process]
Free Article
2.

Prognostic value of preoperative FDG-PET in stage IA lung adenocarcinoma.

Murakami S, Saito H, Sakuma Y, Kondo T, Oshita F, Ito H, Tsuboi M, Hasegawa C, Yokose T, Kameda Y, Nakayama H, Yamada K.

Eur J Radiol. 2012 Aug;81(8):1891-5. doi: 10.1016/j.ejrad.2011.04.007. Epub 2011 May 4.

PMID:
21546177
[PubMed - indexed for MEDLINE]
3.

Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer.

Goodgame B, Pillot GA, Yang Z, Shriki J, Meyers BF, Zoole J, Gao F, Dehdashti F, Patterson A, Siegel BA, Govindan R.

J Thorac Oncol. 2008 Feb;3(2):130-4. doi: 10.1097/JTO.0b013e318160c122.

PMID:
18303432
[PubMed - indexed for MEDLINE]
4.

The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.

Miyasaka Y, Suzuki K, Takamochi K, Matsunaga T, Oh S.

Eur J Cardiothorac Surg. 2013 Jul;44(1):83-7. doi: 10.1093/ejcts/ezs604. Epub 2012 Dec 11.

PMID:
23233074
[PubMed - indexed for MEDLINE]
5.

Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.

Ohara M, Shigematsu H, Tsutani Y, Emi A, Masumoto N, Ozaki S, Kadoya T, Okada M.

Breast. 2013 Oct;22(5):958-63. doi: 10.1016/j.breast.2013.05.003. Epub 2013 Jun 10.

PMID:
23756383
[PubMed - indexed for MEDLINE]
6.

The variation of prognostic significance of Maximum Standardized Uptake Value of [18F]-fluoro-2-deoxy-glucose positron emission tomography in different histological subtypes and pathological stages of surgically resected Non-Small Cell Lung Carcinoma.

Casali C, Cucca M, Rossi G, Barbieri F, Iacuzio L, Bagni B, Uliano M.

Lung Cancer. 2010 Aug;69(2):187-93. doi: 10.1016/j.lungcan.2009.10.015. Epub 2009 Nov 25.

PMID:
19942313
[PubMed - indexed for MEDLINE]
7.

The significance of maximum standardized uptake values in patients with stage I pulmonary adenocarcinoma.

Kim HR, Kim DJ, Lee WW, Jheon S, Sung SW.

Eur J Cardiothorac Surg. 2009 Apr;35(4):712-6; discussion 716-7. doi: 10.1016/j.ejcts.2008.12.030. Epub 2009 Feb 10.

PMID:
19211260
[PubMed - indexed for MEDLINE]
8.

Angiolymphatic invasion exerts a strong impact on surgical outcomes for stage I lung adenocarcinoma, but not non-adenocarcinoma.

Kato T, Ishikawa K, Aragaki M, Sato M, Okamoto K, Ishibashi T, Kaji M.

Lung Cancer. 2012 Aug;77(2):394-400. doi: 10.1016/j.lungcan.2012.04.002. Epub 2012 Apr 27.

PMID:
22542172
[PubMed - indexed for MEDLINE]
9.

Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer.

Choi HJ, Kang CM, Lee WJ, Song SY, Cho A, Yun M, Lee JD, Kim JH, Lee JH.

Yonsei Med J. 2013 Nov;54(6):1377-83. doi: 10.3349/ymj.2013.54.6.1377.

PMID:
24142641
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report.

Namura K, Minamimoto R, Yao M, Makiyama K, Murakami T, Sano F, Hayashi N, Tateishi U, Ishigaki H, Kishida T, Miura T, Kobayashi K, Noguchi S, Inoue T, Kubota Y, Nakaigawa N.

BMC Cancer. 2010 Dec 3;10:667. doi: 10.1186/1471-2407-10-667.

PMID:
21129184
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Prognostic value of 18F-FDG uptake on positron emission tomography in patients with pathologic stage I non-small cell lung cancer.

Um SW, Kim H, Koh WJ, Suh GY, Chung MP, Kwon OJ, Choi JY, Han J, Lee KS, Kim J.

J Thorac Oncol. 2009 Nov;4(11):1331-6. doi: 10.1097/JTO.0b013e3181b6be3e.

PMID:
19701106
[PubMed - indexed for MEDLINE]
12.

Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.

Hyun SH, Choi JY, Kim K, Kim J, Shim YM, Um SW, Kim H, Lee KH, Kim BT.

Ann Surg. 2013 Feb;257(2):364-70. doi: 10.1097/SLA.0b013e318262a6ec.

PMID:
22968069
[PubMed - indexed for MEDLINE]
13.

FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.

Kadota K, Colovos C, Suzuki K, Rizk NP, Dunphy MP, Zabor EC, Sima CS, Yoshizawa A, Travis WD, Rusch VW, Adusumilli PS.

Ann Surg Oncol. 2012 Oct;19(11):3598-605. doi: 10.1245/s10434-012-2414-3. Epub 2012 May 30.

PMID:
22644511
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

[Primary tumor SUVmax measured on (18)F-FDG PET-CT correlates with histologic grade and pathologic stage in non-small cell lung cancer].

Zhao SJ, Wu N, Zheng R, Liu Y, Zhang WJ, Liang Y, Zhang H, Li XM.

Zhonghua Zhong Liu Za Zhi. 2013 Oct;35(10):754-7. Chinese.

PMID:
24378097
[PubMed - indexed for MEDLINE]
16.

Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy.

Onal C, Reyhan M, Parlak C, Guler OC, Oymak E.

Int J Gynecol Cancer. 2013 Jul;23(6):1104-10. doi: 10.1097/IGC.0b013e3182989483.

PMID:
23792605
[PubMed - indexed for MEDLINE]
17.

18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer.

Song BI, Lee SW, Jeong SY, Chae YS, Lee WK, Ahn BC, Lee J.

J Nucl Med. 2012 Sep;53(9):1337-44. doi: 10.2967/jnumed.111.098640. Epub 2012 Jun 29.

PMID:
22870824
[PubMed - indexed for MEDLINE]
Free Article
18.

A clinical study of the prognostic factors for postoperative early recurrence in patients who underwent complete resection for pulmonary adenocarcinoma.

Sakai T, Tsushima T, Kimura D, Hatanaka R, Yamada Y, Fukuda I.

Ann Thorac Cardiovasc Surg. 2011;17(6):539-43. Epub 2011 Jul 27.

PMID:
21881354
[PubMed - indexed for MEDLINE]
Free Article
19.

Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.

Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M.

J Thorac Cardiovasc Surg. 2012 Dec;144(6):1365-71. doi: 10.1016/j.jtcvs.2012.07.012. Epub 2012 Aug 9.

PMID:
22883546
[PubMed - indexed for MEDLINE]
20.

Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy.

Yan H, Wang R, Zhao F, Zhu K, Jiang S, Zhao W, Feng R.

Acta Radiol. 2011 Jul 1;52(6):646-50. doi: 10.1258/ar.2011.100462. Epub 2011 Apr 20. Retraction in: Skjennald A. Acta Radiol. 2012 Jul;53(6):592.

PMID:
21508201
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk